Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Neutral lipid storage disease with myopathy in China: a large multicentric cohort study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Neutral lipid storage disease with myopathy (NLSDM) is a rare clinical heterogeneous disorder caused by mutations in the patatin-like phospholipase domain-containing 2 (PNPLA2) gene. NLSDM usually presents skeletal myopathy, cardiomyopathy and the multiple organs dysfunction. Around 50 cases of NLSDM have been described worldwide, whereas the comprehensive understanding of this disease are still limited. We therefore recruit NLSDM patients from 10 centers across China, summarize the clinical, muscle imaging, pathological and genetic features, and analyze the genotype-phenotype relationship.

          Results

          A total of 45 NLSDM patients (18 men and 27 women) were recruited from 40 unrelated families. Thirteen patients were born from consanguineous parents. The phenotypes were classified as asymptomatic hyperCKemia (2/45), pure skeletal myopathy (18/45), pure cardiomyopathy (4/45), and the combination of skeletal myopathy and cardiomyopathy (21/45). Right upper limb weakness was the early and prominent feature in 61.5% of patients. On muscle MRI, the long head of the biceps femoris, semimembranosus and adductor magnus on thighs, the soleus and medial head of the gastrocnemius on lower legs showed the most severe fatty infiltration. Thirty-three families were carrying homozygous mutations, while seven families were carrying compound heterozygous mutations. A total of 23 mutations were identified including 11 (47.8%) point mutations, eight (34.8%) deletions and four (17.4%) insertions. c.757 + 1G > T, c.245G > A and c.187 + 1G > A were the three most frequent mutations. Among four groups of phenotypes, significant differences were shown in disease onset (< 20 years versus ≥20 years old, p = 0.003) and muscle pathology (with rimmed vacuoles versus without rimmed vacuoles, p = 0.001). PNPLA2 mutational type or functional defects did not show great impact on phenotypes.

          Conclusion

          We outline the clinical and genetic spectrum in a large cohort of NLSDM patients. Selective muscle fatty infiltration on posterior compartment of legs are characteristic of NLSDM. Chinese patients present with distinctive and relative hotspot PNPLA2 mutations. The disease onset age and pathological appearance of rimmed vacuoles are proved to be related with the clinical manifestations. The phenotypes are not strongly influenced by genetic defects, suggesting the multiple environmental risk factors in the development of NLSDM.

          Related collections

          Most cited references33

          • Record: found
          • Abstract: found
          • Article: not found

          The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy.

          Neutral lipid storage disease comprises a heterogeneous group of autosomal recessive disorders characterized by systemic accumulation of triglycerides in cytoplasmic droplets. Here we report a neutral lipid storage disease subgroup characterized by mild myopathy, absence of ichthyosis and mutations in both alleles of adipose triglyceride lipase (PNPLA2, also known as ATGL). Three of these mutations are predicted to lead to a truncated ATGL protein with an intact patatin domain containing the active site, but with defects in the hydrophobic domain. The block in triglyceride degradation was mimicked by short interfering RNA directed against ATGL. NLSDM is distinct from Chanarin-Dorfman syndrome, which is characterized by neutral lipid storage disease with ichthyosis, mild myopathy and hepatomegaly due to mutations in ABHD5 (also known as CGI-58).
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome.

            Chanarin-Dorfman syndrome (CDS) is a rare autosomal recessive form of nonbullous congenital ichthyosiform erythroderma (NCIE) that is characterized by the presence of intracellular lipid droplets in most tissues. We previously localized a gene for a subset of NCIE to chromosome 3 (designated "the NCIE2 locus"), in six families. Lipid droplets were found in five of these six families, suggesting a diagnosis of CDS. Four additional families selected on the basis of a confirmed diagnosis of CDS also showed linkage to the NCIE2 locus. Linkage-disequilibrium analysis of these families, all from the Mediterranean basin, allowed us to refine the NCIE2 locus to an approximately 1.3-Mb region. Candidate genes from the interval were screened, and eight distinct mutations in the recently identified CGI-58 gene were found in 13 patients from these nine families. The spectrum of gene variants included insertion, deletion, splice-site, and point mutations. The CGI-58 protein belongs to a large family of proteins characterized by an alpha/beta hydrolase fold. CGI-58 contains three sequence motifs that correspond to a catalytic triad found in the esterase/lipase/thioesterase subfamily. Interestingly, CGI-58 differs from other members of the esterase/lipase/thioesterase subfamily in that its putative catalytic triad contains an asparagine in place of the usual serine residue.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Therapeutic implications of the gender-specific aspects of cardiovascular disease.

              The manifestations of cardiovascular diseases differ between men and women, as do outcomes after therapeutic interventions. It is important that those involved in drug discovery and development, as well as disease treatment, are aware of these differences because such variations are likely to have an increasing role in therapeutic decisions in the future. Here, I review gender differences in the most frequent cardiovascular diseases and their underlying sex-dependent molecular pathophysiology, and discuss gender-specific effects of current cardiovascular drugs and the implications for novel strategies for drug development.
                Bookmark

                Author and article information

                Contributors
                +86 531 82169217 , chuanzhuyan@163.com
                +86 10 83575783 , yuanyun2002@126.com
                Journal
                Orphanet J Rare Dis
                Orphanet J Rare Dis
                Orphanet Journal of Rare Diseases
                BioMed Central (London )
                1750-1172
                26 October 2019
                26 October 2019
                2019
                : 14
                : 234
                Affiliations
                [1 ]ISNI 0000 0004 1764 1621, GRID grid.411472.5, Department of Neurology, , Peking University First Hospital, ; No.8 Xishiku Street, West District, Beijing, 100034 China
                [2 ]GRID grid.452402.5, Department of Neurology, , Qilu Hospital of Shandong University, ; No. 107, West Wenhua Road, Jinan, 250012 Shandong China
                [3 ]ISNI 0000 0004 1757 8861, GRID grid.411405.5, Department of Neurology, , Huashan Hospital of Fudan University, ; Shanghai, People’s Republic of China
                [4 ]ISNI 0000 0004 0632 4559, GRID grid.411634.5, Department of Neurology, , Peking University People’s Hospital, ; Beijing, People’s Republic of China
                [5 ]GRID grid.452209.8, Department of Neurology, , the Third Hospital of Hebei Medical University, ; Shijiazhuang, Hebei province, People’s Republic of China
                [6 ]GRID grid.412615.5, Department of Neurology, , the First Affiliated Hospital of Sun yat-sen University, ; Guangzhou, Guangdong province, People’s Republic of China
                [7 ]ISNI 0000 0001 0379 7164, GRID grid.216417.7, Department of Neurology, Xiangya Hospital, , Central South University, ; Changsha, Hunan province, People’s Republic of China
                [8 ]GRID grid.412455.3, Department of Neurology, , the Second Affiliated Hospital of Nanchang University, ; Nanchang, Jiangxi province, People’s Republic of China
                [9 ]ISNI 0000 0001 2256 9319, GRID grid.11135.37, Department of Neurology, Third Hospital, , Peking University, ; Beijing, People’s Republic of China
                [10 ]ISNI 0000 0004 1804 3009, GRID grid.452702.6, Department of Neurology, , the Second Hospital of Hebei Medical University, ; Shijiazhuang, Hebei province, People’s Republic of China
                Author information
                http://orcid.org/0000-0003-3282-9123
                Article
                1209
                10.1186/s13023-019-1209-z
                6815004
                31655616
                5fab5f0c-cd33-4dbc-bca6-3bca7ba66e50
                © The Author(s). 2019

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 14 April 2019
                : 24 September 2019
                Funding
                Funded by: National Key Research and Development Program of China
                Award ID: 2016YFC1300600
                Award Recipient :
                Funded by: Beijing Municipal Science and Technology Commission
                Award ID: Z151100003915126
                Award Recipient :
                Categories
                Research
                Custom metadata
                © The Author(s) 2019

                Infectious disease & Microbiology
                neutral lipid storage disease with myopathy,patatin-like phospholipase domain-containing 2,rimmed vacuole,skeletal myopathy,cardiomyopathy

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content343

                Cited by12

                Most referenced authors476